Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-09

Clinical Trial Update: Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial comparing dimethyl sulfoxide (DMSO) alone versus DMSO with botulinum toxin A for bladder pain syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)
  • DMSO (dimethyl sulfoxide)

Snippet

Sponsor: University of Pennsylvania | Conditions: Bladder Pain Syndrome | EARLY_Phase 1 | Status: COMPLETED